Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage-sensitive synaptic pathway that is involved in autism spectrum disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss of a functional copy of the SHANK3 gene leads to the neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders.”
From Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication (2010) · cites this paper as [26]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The variations identified included de novo deleterious mutations and inherited non-synonymous variations affecting highly conserved amino acids in the ankyrin domain.6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The remaining three mutations are non-synonymous mutations located in or near the highly conserved ankyrin domain (R12C, R300C and Q321R, referred to as Shank3R12C, Shank3R300C and Shank3Q321R, respectively).6, 7”
From SHANK3 mutations identified in autism lead to modification of dendritic spine morphology via an actin-dependent mechanism (2012) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent human genetic studies indicate that SHANK family genes (SHANK1, SHANK2, and SHANK3) are causative genes for idiopathic autism spectrum disorders (ASD).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Durand et al., 2007
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In three families from France and Canada, the SHANK3 deletions originated from a balanced translocation present in a healthy parent [6], [13].”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [6]
Experimental — accuracy not yet measured
21 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A forkhead-domain gene is mutated in a severe speech and language disorder
Lai, C. S. L., Fisher, S. E., Hurst, J. A., Vargha-Khadem, F., & Monaco, A. P. (2001) · Nature · doi:10.1038/35097076 · Cited by 2,054
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Self-citationNaisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009
Genetics of austim: complex aetiology for a heterogeneous disorder
Folstein, S. E., & Rosen-Sheidley, B. (2001) · Nature Reviews Genetics · doi:10.1038/35103559 · Cited by 771
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575
Self-citationVorstman, J. A. S., Staal, W. G., van Daalen, E., van Engeland, H., Hochstenbach, P. F. R., & Franke, L. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001757 · Cited by 353
Spine architecture and synaptic plasticity
Carlisle, H. J., & Kennedy, M. B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.01.008 · Cited by 350
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349
Self-citationSevere Expressive-Language Delay Related to Duplication of the Williams–Beuren Locus
Somerville, M. J., Mervis, C. B., Young, E. J., Seo, E.-J., del Campo, M., Bamforth, S., Peregrine, E., Loo, W., Lilley, M., Pérez-Jurado, L. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051962 · Cited by 312
Bonaglia, M. C., Giorda, R., Borgatti, R., Felisari, G., Gagliardi, C., Selicorni, A., & Zuffardi, O. (2001) · The American Journal of Human Genetics · doi:10.1086/321293 · Cited by 309
Cited by
Items 901–1,000 of 1,004
Immune synaptopathies: how maternal immune activation impacts synaptic function during development
Matteoli, M., Pozzi, D., Fossati, M., & Menna, E. (2023) · The EMBO Journal · doi:10.15252/embj.2023113796 · Cited by 18
Mechanisms of copy number variants in neuropsychiatric disorders: From genes to therapeutics
Forrest, M. P., & Penzes, P. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102750 · Cited by 21
Aspectos genéticos y neuroendocrinos en el trastorno del espectro autista
Oviedo, N., Apolinar, L. M., de la Chesnaye, E., & Guerra‐Araiza, C. (2015) · Boletín Médico del Hospital Infantil de México · doi:10.1016/j.bmhimx.2015.01.010 · Cited by 58
Behavioral Profiles in Phelan-McDermid Syndrome: Focus on Mental Health
Shaw, S. R., Rahman, A., & Sharma, A. (2011) · Journal of Mental Health Research in Intellectual Disabilities · doi:10.1080/19315864.2011.554615 · Cited by 21
“Durand and colleagues (2006 ) conducted an extensive study of the relationship between PMS deletion syndrome and ASD.”
Shao, S., Xu, S., Yang, J., Zhang, T., He, Z., Sun, Z., & Song, R. (2014) · Molecular Biology Reports · doi:10.1007/s11033-013-3005-5 · Cited by 20
Genetik autistischer Störungen
Freitag, C. M. (2008) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.36.1.7 · Cited by 17
The genetics and neurobiology of ESSENCE: The third Birgit Olsson lecture
Bourgeron, T. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1042519 · Cited by 21
Self-citationEndosomal system genetics and autism spectrum disorders: A literature review
Patak, J., Zhang‐James, Y., & Faraone, S. V. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.022 · Cited by 23
Genetics of Human Handedness and Laterality
Paracchini, S., & Scerri, T. S. (2017) · Neuromethods · doi:10.1007/978-1-4939-6725-4_16 · Cited by 17
Genetic association between SHANK2 polymorphisms and susceptibility to autism spectrum disorder
Bai, Y., Qiu, S., Li, Y., Li, Y., Zhong, W., Shi, M., Zhu, X., Jiang, H., Yu, Y., Cheng, Y., et al. (2018) · IUBMB Life · doi:10.1002/iub.1876 · Cited by 20
“ASD risk has been found to be associated with the mutations in SHANK3, such as a deletion breakpoint located in intron 8 and a guanine insertion located in exon 21 in three Sweden families (16).”
BackgroundWan, L., Liu, D., Xiao, W., Zhang, B., Yan, X., Luo, Z., & Xiao, B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01054-x · Cited by 23
Wade, M., Prime, H., & Madigan, S. L. (2015) · BioMed Research International · doi:10.1155/2015/672784 · Cited by 23
“SHANK3 22q13 Dendrite morphology regulation; synapse scaffolding and plasticity; binding neuroligins [162, 163] [164]”
BackgroundPhilippe, A., Craus, Y., Rio, M., Bahi‐Buisson, N., Boddaert, N., Malan, V., Bonnefont, J., & Robel, L. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0631-6 · Cited by 19
“The SHANK3 gene codes for a scaffold protein in the postsynaptic densities (PSD) of excitatory glutamatergic synapses in the central and peripheral nervous system [1].”
BackgroundKofuji, T., Hayashi, Y., Fujiwara, T., Sanada, M., Tamaru, M., & Akagawa, K. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.052 · Cited by 18
Khan, F. F., Melton, P. E., McCarthy, N. S., Morar, B., Blangero, J., Moses, E. K., & Jablensky, A. V. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.02.034 · Cited by 20
Khayachi, A., Schorova, L., Alda, M., Rouleau, G. A., & Milnerwood, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.002 · Cited by 16
Lutz, A.-K., Bauer, H. F., Ioannidis, V., Schön, M., & Boeckers, T. M. (2022) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2022.890231 · Cited by 17
Self-citationThe Advent of Nutrigenomics: A Narrative Review with an Emphasis on Psychological Disorders
Birla, M., Choudhary, C., Singh, G., Gupta, S., Bhawana, B., & Pratyusha, V. A. (2022) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2022.27.2.150 · Cited by 20
“As abnormal SHANK3 was associated with cognitive deficits, including autism spectrum disorders, Durand et al. (2007) concluded that mutations in the SHANK3 gene cause autism spectrum disorders.”
BackgroundKim, Y.-E., Kim, M., Kim, S., Lee, R. H., Ujihara, Y., Marquez-Wilkins, E. M., Jiang, Y., Yang, E., Kim, H., Lee, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-56720-1 · Cited by 21
“De fi - ciency in the SHANK3 gene has been reported as a monogenic cause of Phelan-McDermid syndrome (PMS), a neurodevelopmental disorder, characterized by developmental delay, intellectual disability, delayed or absent speech, and lack of sociability 9 – 11 .”
Liu, J., Calhoun, V. D., Chen, J., Claus, E. D., & Hutchison, K. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00393.x · Cited by 18
“Another microdeletion at 22q13 causes the Phelan– McDermid syndrome, and is also associated with autism spectrum disorders (Durand et al. 2007).”
Convergent synaptic and circuit substrates underlying autism genetic risks
McGee, A. W., Li, G., Lu, Z., & Qiu, S. (2014) · Frontiers in Biology · doi:10.1007/s11515-014-1298-y · Cited by 17
“SHANK3 deletions have been reported in patients with autism, intellectual disability and schizophrenia (Bonaglia et al., 2006; Durand et al., 2007; Gauthier et al., 2009), while SHANK3 duplication has been found in Asperger’s patients and patients with intellectual disability (Durand et al., 2007;…”
BackgroundOligonucleotide microarrays in constitutional genetic diagnosis
Keren, B., & Caignec, C. L. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.11.32 · Cited by 19
Cai, G., Wang, M., Wang, S., Liu, Y., Zhao, Y., Zhu, Y., Zhao, S., Zhang, M., Guo, B., Yao, H., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00038 · Cited by 21
“Genetic defects of SHANK3 (PROSAP2) are one of the most replicated findings in autism genetics (1, 2).”
BackgroundFischer, I., Shohat, S., Levy, G., Bar, E., Trangle, S. S., Efrati, S., & Barak, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911077 · Cited by 20
“It is a scaffold protein whose main role is to bind glutamate receptors to the cytoskeleton and therefore is essential for synaptic transmission and integrity [1,4,6].”
BackgroundTakada, Y., Hirano, M., Kiyonaka, S., Ueda, Y., Yamaguchi, K., Nakahara, K., Mori, M. X., & Mori, Y. (2015) · Cell Calcium · doi:10.1016/j.ceca.2015.06.007 · Cited by 19
Genetic testing for autism: recent advances and clinical implications
Miller, D. T. (2010) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.82 · Cited by 16
De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention
Gauthier, J., & Rouleau, G. A. (2012) · Genome Medicine · doi:10.1186/gm372 · Cited by 16
Genetic Causes of Autism Spectrum Disorders
Huguet, G., & Bourgeron, T. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00002-9 · Cited by 20
Self-citationAutism Spectrum Disorders: The Role of Genetics in Diagnosis and Treatment
Deutsch, S. I. (2011) · InTech eBooks · doi:10.5772/976 · Cited by 22
Shank is a dose-dependent regulator of Cav1 calcium current and CREB target expression
Pym, E. C. G., Sasidharan, N., Thompson-Peer, K. L., Simon, D. J., Anselmo, A. N., Sadreyev, R. I., Hall, Q., Nurrish, S., & Kaplan, J. M. (2017) · eLife · doi:10.7554/elife.18931 · Cited by 20
“Implications for understanding psychiatric disorders In humans, Shank deletions and duplications both confer risk for ASD and schizophrenia (Bonaglia et al., 2006; Durand et al., 2007; Failla et al., 2007; Gauthier et al., 2010; Han et al., 2013).”
BackgroundInfluentialTordjman, S., Cohen, D., Coulon, N., Anderson, G. M., Botbol, M., Canitano, R., & Roubertoux, P. L. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.030 · Cited by 22
Molecular Windows into Speech and Language Disorders
Fisher, S. E. (2007) · Folia Phoniatrica et Logopaedica · doi:10.1159/000101771 · Cited by 18
“and disruption of one copy of the SHANK3 gene in autism spectrum disorders [”
BackgroundPharmacology and Genetics of Autism: Implications for Diagnosis and Treatment
Brkanac, Z., Raskind, W. H., & King, B. H. (2008) · Personalized Medicine · doi:10.2217/17410541.5.6.599 · Cited by 20
Genetic Findings as the Potential Basis of Personalized Pharmacotherapy in Phelan-McDermid Syndrome
Dyar, B., Meaddough, E. L., Sarasua, S. M., Rogers, C. R., Phelan, K., & Boccuto, L. (2021) · Genes · doi:10.3390/genes12081192 · Cited by 15
Overgrowth Syndromes: A Classification
Neri, G., & Moscarda, M. (2009) · Endocrine development · doi:10.1159/000207476 · Cited by 15
Phelan, K., Boccuto, L., & Sarasua, S. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00021-2 · Cited by 18
Early Origin and Evolution of the Angelman Syndrome Ubiquitin Ligase Gene Ube3a
Sato, M. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00062 · Cited by 21
“Shank postsynaptic scaffold proteins have been implicated in autism spectrum disorders in humans (Durand et al., 2007; Berkel et al., 2010; Sato et al., 2012) and are also found in the choanoflagellate genome (Alié and Manuel, 2010), providing another remarkable example of the ancient origins of…”
BackgroundWin‐Shwe, T., Kyi‐Tha‐Thu, C., Fujitani, Y., Tsukahara, S., & Hirano, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020538 · Cited by 17
“NLGN3, NLGN4X and SHANK3 are synaptic genes and mutation of these genes are involved in idiopathic autism [32-36].”
BackgroundWoike, D., Wang, E., Tibbe, D., Nia, F. H., Failla, A. V., Kibæk, M., Overgård, T. M., Larsen, M. J., Fagerberg, C. R., Barsukov, I., et al. (2022) · Scientific Reports · doi:10.1038/s41598-021-04723-5 · Cited by 17
“Curr Opin Neurobiol, 22(3), 522-9 (2012) doi:10.”
BackgroundInfluentialSingh, G., Singh, V., Kim, T. J., Ertel, A., Fu, W., & Schneider, J. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-15861-9 · Cited by 17
Wang, Q.-W., Qin, J., Chen, Y., Tu, Y., Xing, Y.-Y., Wang, Y., Yang, L.-Y., Lu, S., Geng, L., Shi, W., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112691 · Cited by 25
Cantor, R. M. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0021-1 · Cited by 16
Etiology of Autism Spectrum Disorder: A Genomics Perspective
Connolly, J. J., & Hakonarson, H. H. (2014) · Current Psychiatry Reports · doi:10.1007/s11920-014-0501-9 · Cited by 22
Mice lacking GRIP1/2 show increased social interactions and enhanced phosphorylation at GluA2-S880
Han, M., Mejías, R., Chiu, S., Rose, R., Adamczyk, A. L., Huganir, R. L., & Wang, T. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.12.042 · Cited by 16
Ponna, S. K., Myllykoski, M., Boeckers, T. M., & Kursula, P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.121 · Cited by 14
“Within the SH3 domain, S557N and R569H in Shank2 and H493Q in Shank3 have been reported; Shank2 S557N was observed more frequently in ASD patients than controls [35].”
BackgroundInfluentialSelf-citationQiu, S., Li, Y., Bai, Y., Shi, J., Cui, H., Gu, Y., Ren, Y., Zhao, Q., Zhang, K., Lu, M., et al. (2019) · Autism Research · doi:10.1002/aur.2065 · Cited by 17
“Deletions, duplications, and coding mutations in SHANK have been found in patients with ASD [Durand et al., 2007; Gauthier et al., 2009; Moessner et al., 2007; Phelan & McDermid, 2012; Pinto et al., 2010; Sanders et al., 2011; Sato et al., 2012; Soorya et al., 2013].”
BackgroundA chimeric mouse model to study human iPSC-derived neurons: the case of a truncating SHANK3 mutation
Vitrac, A., Pons, S., Bałkota, M., Lemière, N., Raïs, C., Bourgeois, J., Maskos, U., Bourgeron, T., & Cloëz-Tayarani, I. (2020) · Scientific Reports · doi:10.1038/s41598-020-70056-4 · Cited by 16
Self-citationFulminant hepatic failure requiring liver transplantation in 22q13.3 deletion syndrome
Bartsch, O., Schneider, E., Damatova, N., Weis, R., Tufano, M., Iorio, R. F., Ahmed, A., Beyer, V., Zechner, U., & Haaf, T. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33542 · Cited by 15
Sadakata, T., Shinoda, Y., Sato, A., Iguchi, H., Ishii, C., Matsuo, M., Yamaga, R., & Furuichi, T. (2013) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph10126335 · Cited by 16
Copy-Number Variations Associated with Autism Spectrum Disorder
Kakinuma, H., & Sato, H. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.8.1143 · Cited by 17
Autism Spectrum Disorder: The Cerebellum, Genes, and Pathways
D’Mello, S. R. (2025) · Neurology International · doi:10.3390/neurolint17100173 · Cited by 17
“Other loss-of-function mutations of SHANK3, which include large deletions and insertions, point mutations, and splicing mutations, have been linked to non-syndromic ASDs [189,205–207].”
Autism-associated gene shank3 is necessary for social contagion in zebrafish
Kareklas, K., Teles, M. C., Dreosti, E., & Oliveira, R. F. (2023) · Molecular Autism · doi:10.1186/s13229-023-00555-4 · Cited by 15
Arai, T., Kamagata, K., Uchida, W., Andica, C., Takabayashi, K., Saito, Y., Tuerxun, R., Mahemuti, Z., Morita, Y., Irie, R., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1110883 · Cited by 15
Taylor, M. J., Charman, T., Robinson, E., Hayiou‐Thomas, M. E., Happe, F. G. E., Dale, P. S., & Ronald, A. (2014) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32262 · Cited by 21
Does treatment of premature labor with terbutaline increase the risk of autism spectrum disorders?
Rodier, P. M., Miller, R. K., & Brent, R. L. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.11.030 · Cited by 15
“Many developmental pathways seem to be involved and include those that have roles in initiating or maintaining synapses.(6,7) The penetrance of the genetic liability factors is variable so that symptoms differ, even in pairs of monozygotic twins.”
Pathogenesis of Autism: A Patchwork of Genetic Causes
Grigorenko, E. L. (2009) · Future Neurology · doi:10.2217/fnl.09.29 · Cited by 17
Shen, X., Yeung, H. T., & Lai, K. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22644 · Cited by 16
SHANK3 Co-ordinately Regulates Autophagy and Apoptosis in Myocardial Infarction
Man, W., Gu, J., Wang, B., Zhang, M., Hu, J., Lin, J. M., Sun, D., Xiong, Z., Gu, X., Hao, K., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.01082 · Cited by 16
“show that SHANK3 is responsible for autism spectrum disorders (ASDs), intellectual disability (ID), and schizophrenia (Durand et al., 2007; Moessner et al., 2007; Leblond et al., 2014).”
BackgroundProtein Phosphorylation Signaling Cascades in Autism: The Role of mTOR Pathway
Бокша, И. С., Prokhorova, T. A., Терешкина, Е. Б., Savushkina, O. K., & Burbaeva, G. S. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921050072 · Cited by 15
Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier
Klaassen, K., Djordjevic, M., Skakić, A., Kecman, B., Drmanac, R., Pavlović, S., & Stojiljković, M. (2021) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2021.100822 · Cited by 17
Transient hearing abnormalities precede social deficits in a mouse model of autism
Pang, R., Yan, S., Tu, Y., Qian, S., Yu, H., Hu, X., Wen, H., Yuan, W., Wang, X., & Zhou, Y. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114149 · Cited by 13
Glutamatergic agents in Autism Spectrum Disorders: Current trends
Canitano, R., & Scandurra, V. (2014) · Research in Autism · doi:10.1016/j.rasd.2013.12.009 · Cited by 14
Kanani, F., Study, D., & Balasubramanian, M. (2018) · Clinical Dysmorphology · doi:10.1097/mcd.0000000000000232 · Cited by 16
Zhang, L., Liu, L., Wen, Y. F., Ma, M., Cheng, S., Yang, J., Li, P., Cheng, B., Du, Y., Liang, X., et al. (2018) · Autism Research · doi:10.1002/aur.2001 · Cited by 18
New Horizons for Molecular Genetics Diagnostic and Research in Autism Spectrum Disorder
Al-Dewik, N. I. E., & Alsharshani, M. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_2 · Cited by 13
Torossian, A., Saré, R. M., Loutaev, I., & Smith, C. B. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105213 · Cited by 15
“Our results demonstrating a link between loss of a synaptic protein and changes in mRNA translation have implications for understanding of PMS and perhaps even ASDs in general.”
BackgroundInfluentialAbrahams, B. S., & Geschwind, D. H. (2009) · Springer eBooks · doi:10.1007/978-3-540-37654-5_29 · Cited by 15
The genetic landscape of autism spectrum disorder in the Middle Eastern population
Al-Sarraj, Y. A., Taha, R. Z., Al‐Dous, E., Ahram, D. F., Abbasi, S., Abuazab, E., Shaath, H., Habbab, W., Errafii, K., Bejaoui, Y., et al. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1363849 · Cited by 16
Variants in LRRC7 lead to intellectual disability, autism, aggression and abnormal eating behaviors
Willim, J., Woike, D., Greene, D., Das, S., Pfeifer, K., Yuan, W., Lindsey, A., Itani, O. A., Böhme, A. L., Tibbe, D., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52095-x · Cited by 18
“…CTNNB1 ; coding for β -catenin; CTNND2 ; coding for δ - catenin; SHANK2 , SHANK3 ) are associated with neurodevelopmental disorders (NDD) in humans 15 – 18 , LRRC7 has Here, we identify a group of 33 patients (including one of the previously published cases 20 ), each of whom carries a rare…”
Molecular Pathways, Neural Circuits and Emerging Therapies for Self-Injurious Behaviour
Zhang, K., Ibrahim, G. M., & Gouveia, F. V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051938 · Cited by 17
“…animal studies has led to the identification of a wide array of therapeutic targets, including the Mecp2 gene and protein product, as well as the downstream mechanisms (i.e., neurotransmitter pathways, metabolic pathways, and ion channels) involved in SIB related to the Mecp2 mutation [109,110].”
Canitano, R. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.024 · Cited by 16
Genomic Strategies for Understanding the Pathophysiology of Autism Spectrum Disorder
Doi, M., Li, M., Usui, N., & Shimada, S. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.930941 · Cited by 13
“For example, one of the frequently reported ASD genes, SHANK3, is a multidomain scaffold protein involved in the regulation of the structural organization of dendritic spines (Durand et al., 2007).”
BackgroundGenetic and environmental mouse models of autism reproduce the spectrum of the disease
Jaber, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02555-9 · Cited by 15
“Shank 3 gene mutations were first implicated in the Phelan-McDermid Syndrome (Durand et al. 2007).”
BackgroundInfluentialGąssowska-Dobrowolska, M., Kolasa, A., Beversdorf, D. Q., & Adamczyk, A. (2022) · Biomedicines · doi:10.3390/biomedicines10123031 · Cited by 13
Anatomy and Cell Biology of Autism Spectrum Disorder: Lessons from Human Genetics
Kleijer, K. T. E., Huguet, G., Tastet, J., Bourgeron, T., & Burbach, J. P. H. (2017) · Advances in anatomy, embryology and cell biology · doi:10.1007/978-3-319-52498-6_1 · Cited by 13
Self-citationMorris, C. W., Watkins, D. S., Shah, N. R., Pennington, T., Hens, B., Qi, G. D., Doud, E. H., Mosley, A. L., Atwood, B. K., & Baucum, A. J. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.12.008 · Cited by 14
Huang, C., Voglewede, M. M., Ozsen, E. N., Wang, H., & Zhang, H. (2023) · Neuroscience · doi:10.1016/j.neuroscience.2023.07.024 · Cited by 17
Effect of Enriched Environment on Cerebellum and Social Behavior of Valproic Zebrafish
Flores-Prieto, B., Salazar, F., Manzo, J., Hernández‐Aguilar, M. E., Coria‐Ávila, G. A., Herrera‐Covarrubias, D., Rojas-Durán, F., Aranda-Abreu, G. E., Pérez-Estudillo, C. A., & Toledo‐Cárdenas, M. R. (2024) · NeuroSci · doi:10.3390/neurosci5020009 · Cited by 12
“This could be attributed to changes in genes like Shank3, known for its involvement in synapse formation and frequently altered in individuals with ASD and in response to VPA exposure [58–60].”
BackgroundModeling autism spectrum disorders in zebrafish
Dreosti, E., Hoffman, E. J., & Rihel, J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817528-6.00026-7 · Cited by 13
The Genetic Control of Stoichiometry Underlying Autism
Darnell, R. B. (2020) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-100119-024851 · Cited by 12
“Moreover, point mutations in SHANK3 are associated with ASD (Durand et al. 2007, Ruzzo et al. 2019), restoration of SHANK3 function in SHANK3-deleted neurons restores synaptic deficits (Shcheglovitov et al. 2013), and similar findings of reversible autism-like defects were observed in mice…”
BackgroundMegagiannis, P., Suresh, R., Rouleau, G. A., & Zhou, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114562 · Cited by 12
Expression profiles of the autism-related SHANK proteins in the human brain
Woelfle, S., Pedro, M. T., Wagner, J., Schön, M., & Boeckers, T. M. (2023) · BMC Biology · doi:10.1186/s12915-023-01712-0 · Cited by 17
“The indispensable role of SHANKs in human brains was first revealed by the causative role of SHANK3 haploinsufficiency in Phelan-McDermid syndrome (PMDS) [5, 6], “a syndromic form of autism spectrum disorders (ASD)” [7].”
BackgroundSelf-citationA blueprint for research on Shankopathies: A view from research on autism spectrum disorder
Carbonetto, S. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22150 · Cited by 16
“The “synaptic hypothesis” has arisen largely from the research on monogenic disorders, such as fragile X syndrome, PMS, Tuberous sclerosis complex (TSC), and Rett Syndrome, where penetrance is high.”
BackgroundInfluentialQiu, Z., & Cheng, J. (2010) · Neurosignals · doi:10.1159/000320970 · Cited by 13
“Since protein ubiquitination is a universal reaction happening in almost every physiological process within the cell, it is still hard to understand why loss of Ube3a causes abnormalities in neural development. There may be some specific signatures in functionally important proteins which is processed by Ube3a during…”
BackgroundEffect of experimental genital mycoplasmosis on gene expression in the fetal brain
Burton, A., Kizhner, O., Brown, M. B., & Peltier, M. R. (2012) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2011.11.005 · Cited by 12
“SHANK-3 expression through a mis-sense mutation has been demonstrated to be strongly linked to ASD (Durand et al., 2007; Gauthier et al., 2009; Moessner et al., 2007); however, we found greater levels of expression of this gene in animals infected with M.”
BackgroundThe Role of the Postsynaptic Density in the Pathology of the Fragile X Syndrome
Kindler, S., & Kreienkamp, H. (2011) · Results and problems in cell differentiation · doi:10.1007/978-3-642-21649-7_5 · Cited by 13
Sagar, A., Pinto, D., Najjar, F., Guter, S. J., Macmillan, C., & Cook, E. H. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38171 · Cited by 12
“Because disruptions of SHANK3 and ofDLGAP2 have been associatedwith ASD (Durand et al., 2007; Gau et al., 2010), it is possible that a deletion of DLGAP2 contributed to our patient's autism (Pinto et al., 2010; Romorini et al., 2004).”
BackgroundCharacterization of the zinc-induced Shank3 interactome of mouse synaptosome
Lee, Y., Ryu, J. R., Kang, H., Kim, Y., Kim, S., Zhang, Y., Jin, C., Cho, H. M., Kim, W.-K., Sun, W., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.143 · Cited by 13
Mice lacking neuronal calcium sensor-1 show social and cognitive deficits
Ng, E., Georgiou, J., Ávila, A., Trought, K., Mun, H.-S., Hodgson, M., Servinis, P., Roder, J., Collingridge, G. L., & Wong, A. H. C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112420 · Cited by 15
Stem Cells for Improving the Treatment of Neurodevelopmental Disorders
Donegan, J. J., & Lodge, D. J. (2020) · Stem Cells and Development · doi:10.1089/scd.2019.0265 · Cited by 14
“SHANK3 mutations have been linked to autism [127,128] and SHANK3 KO mice show autism-like behavioral deficits and reduced excitatory synapses [129].”
BackgroundBenchoua, A., Lasbareilles, M., & Tournois, J. (2021) · Cells · doi:10.3390/cells10123290 · Cited by 15
Neural phenotypes of common and rare genetic variants
Bearden, C. E., Glahn, D. C., Lee, A. D., Chiang, M.-C., van Erp, T. G. M., Cannon, T. D., Reiss, A. L., Toga, A. W., & Thompson, P. M. (2008) · Biological Psychology · doi:10.1016/j.biopsycho.2008.02.005 · Cited by 13
“Notably, the trisomic region in these patients included the SHANK3 gene, which is important for synaptic scaffolding; mutations in this gene have also been associated with autism (Durand et al., 2007).”
BackgroundGenome Variation and Complexity in the Autism Spectrum
van de Lagemaat, L. N., & Grant, S. G. N. (2010) · Neuron · doi:10.1016/j.neuron.2010.06.026 · Cited by 12
“…however, the authors cite the fact that mutations in these proteins, their interacting partners, Neu or their paralogs have been implicated before in ASD or mental retardation (Durand et al., 2007; Hamdan et al., 2009; Romorini et al., 2004), which helps to build the case for their relevance.”
BackgroundDeficiency of FRMD5 results in neurodevelopmental dysfunction and autistic-like behavior in mice
Lyu, T., Ma, J., Zhang, X.-Y., Xie, G., Liu, C., Du, J., Xu, Y.-N., Yang, D.-C., Cen, C., Wang, M.-Y., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02407-w · Cited by 12
“Among the highlights of these studies, some scaffolding proteins found by sequencing show innate effects on ASD developmental dysfunction [7, 8].”
Caregiver perspectives on patient-focused drug development for Phelan-McDermid syndrome
Gizzo, L., Bliss, G., Palaty, C., & Kolevzon, A. L. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03141-w · Cited by 11
“SHANK3 deletions or sequence variants are among the most common causes of ASD, accounting for 0.5—2% of ASD cases [5–7].”
BackgroundInfluentialChung, M., Imanaka, K., Huang, Z., Watarai, A., Wang, M., Tao, K., Ejima, H., Aida, T., Feng, G., & Okuyama, T. (2024) · Nature Communications · doi:10.1038/s41467-024-48430-x · Cited by 12
“Among these genes, SH3 and multiple ankyrin repeat domains 3 (Shank3), which encodes a glutamatergic postsynaptic scaffolding protein, is one of the most promising ASD candidate genes 7,8 .”
BackgroundMapping the Behavioral Signatures of Shank3b Mice in Both Sexes
Liu, J., Ye, J., Ji, C., Ren, W., He, Y., Xu, F., & Wang, L. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01237-8 · Cited by 13
“More detailly, ASD patients, including rodents with Shank3 mutations [14, 15, 40], are frequently reported with motor dysfunction [15, 41–43].”
BackgroundUnravelling the role of SHANK3 mutations in targeted therapies for autism spectrum disorders
Li, X. (2024) · Discover Psychology · doi:10.1007/s44202-024-00223-5 · Cited by 14
“Disruptions in SHANK3 and its associated proteins can lead to synaptic dysfunction, a hallmark of ASD [8].”
Therapeutic development approaches to treat haploinsufficiency diseases: restoring protein levels
Evans, E. F., Shyr, Z. A., Traynor, B. J., & Zheng, W. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104201 · Cited by 14
Jin, F., & Wang, Z. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1514678 · Cited by 16
Metadata
- Authors
- Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., Sponheim, E., Goubran-Botros, H., Delorme, R., Chabane, N., Mouren-Simeoni, M.-C., de Mas, P., Bieth, E., Rogé, B., Héron, D., Burglen, L., Gillberg, C., Leboyer, M., & Bourgeron, T.
- Affiliations
- Institut Pasteur (FR)
- Inserm (FR)
- Universität Ulm (DE)
- University of Gothenburg (SE)
- University of Oslo (NO)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Toulouse - Jean Jaurès (FR)
- Pitié-Salpêtrière Hospital (FR)
- St George's Hospital (GB)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-12-17
- Volume
- 39
- Issue
- 1
- Pages
- 25-27
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2082049
- OpenAlex
- W1983194657
- Cited by
- 1,602
- References
- 16
- Citations by year
- 2026: 48 · 2025: 40 · 2024: 75 · 2023: 71 · 2022: 78 · 2021: 91 · 2020: 85 · 2019: 68 · 2018: 81 · 2017: 99 · 2016: 79 · 2015: 96 · 2014: 78 · 2013: 97 · 2012: 114
- FWCI
- 33.51
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- George Washington University
- Georgetown University
- Children's National Hospital
- European Commission
- Deutsche Forschungsgemeinschaft (SFB 497)
- Institut National de la Santé et de la Recherche Médicale
- Fondation pour la Recherche Médicale
- Fondation de France
- Universitetet i Oslo
- Assistance publique-Hôpitaux de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- SHANK3, autism spectrum disorder, neuroligins, dendritic spines, synaptic scaffolding, chromosome 22q13, gene dosage sensitivity, language disorders, social communication disorder, Asperger syndrome
- MeSH terms
- Autistic Disorder, Base Sequence, Carrier Proteins, DNA Mutational Analysis, Female, Genetic Testing, Humans, Male, Molecular Sequence Data, Mutation, Nerve Tissue Proteins, Pedigree, In Situ Hybridization, Fluorescence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.